Geoffrey L. Uy - Concepedia

Author

Geoffrey L. Uy

Washington University in St. Louis ORCID

Also Known As

Celalettin Ustun, G L Uy, G Uy, G. L. Uy, G. Uy, G.L. Uy, Geoff Uy, Geoffery L. Uy, Geoffrey L Uy, Geoffrey L. Uy

460

Publications

14.3K

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis Dana-Farber Cancer Institute The University of Texas MD Anderson Cancer Center The Ohio State University Memorial Sloan Kettering Cancer Center

About

Geoffrey L. Uy is an author at Washington University in St. Louis specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	48	3.4K
2	Health Sciences	14	21	2K
3	Engineering	3	3	149
4	Natural Sciences	1	1	194
5	Public Health	1	1	21

Geoffrey L. Uy

136

Publications

12.7K

Citations

H-Index

Page 1

	Year	Citations
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton, New England Journal of Medicine	2018	1.4K
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia Jeffrey E. Lancet, Geoffrey L. Uy, Jörge E. Cortes, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaPharmacotherapyMetronomic ChemotherapyMyeloid NeoplasiaHematological Malignancy	2018	958
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes John S. Welch, Allegra A. Petti, Christopher A. Miller, New England Journal of Medicine	2016	774
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100 Bruno Nervi, Pablo Ramírez, Michael P. Rettig, Blood	2008	477
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia Geoffrey L. Uy, Michael P. Rettig, Ibraheem Motabi, Blood	2012	381
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia Gail J. Roboz, Courtney D. DiNardo, Eytan M. Stein, Blood	2019	363
Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation Iskra Pusic, Shi Yuan Jiang, Scott Landua, Biology of Blood and Marrow Transplantation	2008	348
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster, Blood	2020	307
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers Eric J. Duncavage, Molly C. Schroeder, Michele O’Laughlin, New England Journal of Medicine	2021	282
Acute Lymphoblastic Leukemia, Version 2.2015 Joseph Alvarnas, Patrick A. Brown, Patricia Aoun, Journal of the National Comprehensive Cancer Network	2015	239

Page 1